Yamauchi N, Shibasaki T, Wakabayashi I, Demura H
Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical College, Japan.
Brain Res. 1997 Nov 28;777(1-2):140-6. doi: 10.1016/s0006-8993(97)01097-4.
Opiates and opioids have complex effects on the hypothalamic-pituitary-adrenal axis, and they stimulate the sympathetic nervous system. This study was designed to clarify the role of brain beta-endorphin in the mechanism by which stress increases plasma concentrations of adrenocorticotropin (ACTH), epinephrine (E), and norepinephrine (NE). Intracerebroventricular (i.c.v.) administration of beta-endorphin to rats significantly increased plasma ACTH levels at doses of 0.09, 0.3, and 1.5 nmol, and plasma E and NE levels at doses of 0.3 and 1.5 nmol. The rise of plasma ACTH, E, and NE levels by 0.3 nmol beta-endorphin was inhibited by intravenous (i.v.) administration of 2 mg/kg b.wt. naloxone. I.v. administration of anti-rat corticotropin-releasing hormone (CRH) rabbit serum completely blocked the beta-endorphin-induced ACTH secretion without affecting the secretion of E and NE. I.c.v. administration of anti-beta-endorphin rabbit gamma-globulin attenuated a 30-min restraint stress-induced rise of plasma ACTH levels without significant influence on the rise of E and NE levels, whereas i.v. administration of naloxone attenuated the restraint stress-induced rise of plasma ACTH, E and NE levels. These results suggest that i.c.v. administration of beta-endorphin stimulates the secretion of ACTH, E, and NE through opiate receptor, and that brain CRH mediates the beta-endorphin-induced secretion of ACTH. The results also suggest that brain beta-endorphin is, at least in part, involved in the restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, and that some opioids other than beta-endorphin are involved in the stimulatory mechanism of the autonomic nervous system and the adrenal medulla in the rat.
阿片类药物对下丘脑 - 垂体 - 肾上腺轴有复杂的影响,并且它们会刺激交感神经系统。本研究旨在阐明脑内β - 内啡肽在应激增加促肾上腺皮质激素(ACTH)、肾上腺素(E)和去甲肾上腺素(NE)血浆浓度的机制中所起的作用。向大鼠脑室内(i.c.v.)注射β - 内啡肽,剂量为0.09、0.3和1.5 nmol时可显著提高血浆ACTH水平,剂量为0.3和1.5 nmol时可提高血浆E和NE水平。静脉内(i.v.)注射2 mg/kg体重的纳洛酮可抑制0.3 nmolβ - 内啡肽引起的血浆ACTH、E和NE水平升高。静脉注射抗大鼠促肾上腺皮质激素释放激素(CRH)兔血清可完全阻断β - 内啡肽诱导的ACTH分泌,而不影响E和NE的分泌。脑室内注射抗β - 内啡肽兔γ - 球蛋白可减弱30分钟束缚应激诱导的血浆ACTH水平升高,而对E和NE水平升高无显著影响,而静脉注射纳洛酮可减弱束缚应激诱导的血浆ACTH、E和NE水平升高。这些结果表明,脑室内注射β - 内啡肽通过阿片受体刺激ACTH、E和NE的分泌,并且脑CRH介导β - 内啡肽诱导的ACTH分泌。结果还表明,脑内β - 内啡肽至少部分参与了束缚应激诱导的下丘脑 - 垂体 - 肾上腺轴的刺激,并且除β - 内啡肽外的一些阿片类药物参与了大鼠自主神经系统和肾上腺髓质的刺激机制。